Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

BACKGROUND: To ensure the highest quality of human papillomavirus (HPV) testing in primary cervical cancer screening, novel HPV assays must be evaluated in accordance with the international guidelines. Furthermore, HPV assay with genotyping capabilities are becoming increasingly important in triage...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Ejegod, Ditte Møller, Lagheden, Camilla, Bhatia, Ramya, Pedersen, Helle, Boada, Elia Alcañiz, Sundström, Karin, Cortés, Javier, Josë, F. Xavier Bosch, Cuschieri, Kate, Dillner, Joakim, Bonde, Jesper
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7203972/
https://ncbi.nlm.nih.gov/pubmed/32375689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-06888-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados